Skip to main content
Clinical Development

Phase 1 Clinical Trial

First-in-human studies primarily assessing safety, tolerability, and pharmacokinetics in a small number of subjects (typically 20-80).

See How Phase 1 Clinical Trial Affects Deal Economics

Model deal terms with real benchmark data from 3,000+ biopharma transactions.

Try the CalculatorBrowse All Terms